Skip to content
Screener

Corvus Pharmaceuticals CRVS Q2 2026 earnings

Reported August 6, 2026 · After market close

EPS-$0.19Miss by $0.03
EPS estimate-$0.16

Next report

Nov 3, 2026 (in a month)
EPS estimate-$0.21

FAQ

When did Corvus Pharmaceuticals report Q2 2026 earnings?
Corvus Pharmaceuticals (CRVS) reported Q2 2026 earnings on August 6, 2026 after market close.
What were Corvus Pharmaceuticals's Q2 2026 revenue and EPS?
Corvus Pharmaceuticals reported eps of $-0.19 for Q2 2026.
Did Corvus Pharmaceuticals beat estimates in Q2 2026?
EPS missed the consensus estimate of $-0.16 by $0.03.
How did Corvus Pharmaceuticals's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 90.0% from $-0.10.
Where can I find Corvus Pharmaceuticals's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001171843-26-005317) and the 10-Q periodic report (0001104659-26-091975) directly on SEC EDGAR. The filing index links above go to sec.gov.